ANIP.US ANI Pharmaceuticals Inc

Healthcare Pharmaceuticals USA Stocks
71.47 USD
Close of Nov 13, 2026
67.14 87.76
Market cap
USD 1.62B
P/E
14.2x
P/B
2.53x
ROE
18.7%
Dividend yield
0.07%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ANIP.US undervalued?

Graham number
Price71.47
Graham value56.54
Premium26.4%

ANIP.US trades 26.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ANI Pharmaceuticals Inc fundamental analysis

No fundamental analysis for ANI Pharmaceuticals Inc yet.

ANI Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty …

Full company profile